Target intelligence / Profile preview

RN7SK pseudogene 15 (RN7SKP15)

Target
RN7SKP15
Molecular classification
Other, Pseudogene (processed pseudogene of small nuclear RNA)
01

Overview

RN7SK pseudogene 15 (RN7SKP15) is classified as a processed pseudogene of the 7SK small nuclear RNA gene. Unlike the functional RN7SK, which regulates RNA polymerase II transcriptional elongation and splicing via interaction with the positive transcription elongation factor b (P-TEFb)[1][2], RN7SKP15 does not produce a functional RNA or protein product and has not been implicated in any known biological roles, diseases, or as a therapeutic target. No information suggests that RN7SKP15 is expressed, functional, or druggable. The functional RN7SK RNA (not RN7SKP15, but the parent gene) is known to orchestrate control of transcriptional pausing and regulate the activity of RNA polymerase II, thereby influencing cellular differentiation, cell cycle progression, and immune cell polarization[1][2]. However, RN7SKP15 is only a pseudogene, without evidence for transcriptional activity or biological relevance. Most gene and functional references found in the literature pertain specifically to RN7SK, not its pseudogenes. RN7SKP15 is not a canonical receptor, enzyme, transporter, or drug target. It is a pseudogene of RN7SK, and no scientific evidence supports its use as a therapeutic or diagnostic target. If your intention is to investigate the functional 7SK small nuclear RNA, refer instead to RN7SK or its roles in Pol II transcriptional regulation[1][2]. If you want information about the pseudogene RN7SKP15, there is no evidence of function, disease role, or therapeutic relevance.

Other names
RNA, 7SK small nuclear pseudogene 15RN7SKP15
02

Mechanism of action

None (this entity does not encode a functional product)

03

Biological functions

None known (as it is a pseudogene, there is no validated function)
04

Disease associations

None known or reported in the literature
05

Safety considerations

None relevant (not a functional or therapeutic target)
06

Interacting drugs

None (no evidence of any drugs targeting this pseudogene)
07

Biomarkers

None established

Beyond the preview

Go deeper on RN7SK pseudogene 15 (RN7SKP15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 15 (RN7SKP15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call